Literature DB >> 9507999

Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet.

W R Fisher1, L A Zech, P W Stacpoole.   

Abstract

The effect on apolipoprotein B kinetics of a diet enriched in either fish oil or safflower oil was investigated in five hypertriglyceridemic (HTG), non-insulin-dependent diabetic subjects. The fish oil diet decreased plasma triglycerides and VLDL-apoB but increased LDL-apoB and LDL-cholesterol. Total plasma apoB concentration did not change, nor did the increased VLDL-apoB secretion present in these HTG subjects, which, accompanied by impaired lipolysis, accounted for their elevated VLDL. The fish oil-induced fall in VLDL resulted from a decrease in secretion without a change in residence time. The IDL fraction, which also contained small VLDL, was the primary site for the secretion of apoB particles in the HTG subjects. On the fish oil diet there was a further, compensatory increase in the secretion of these lipoproteins such that the transport of apoB in IDL remained the same, as did its mass. In the HTG subjects the major portion of IDL lipoproteins was catabolized, with LDL-apoB production comprising the lesser quantity. On the fish oil diet, a shift in the channeling of the lipoprotein output from IDL resulted in a decrease in the catabolic pathway and an increase in conversion to LDL. As the residence time of LDL did not change, this increased input gave rise to the larger mass of LDL-apoB seen in these hypertriglyceridemic subjects when receiving a fish oil diet.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507999

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Fish oil -- how does it reduce plasma triglycerides?

Authors:  Gregory C Shearer; Olga V Savinova; William S Harris
Journal:  Biochim Biophys Acta       Date:  2011-10-25

2.  Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia.

Authors:  L Aldámiz-Echevarría; P Sanjurjo; J Elorz; J A Prieto; C Pérez; F Andrade; J Rodríguez-Soriano
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 3.  Fish oil for the treatment of cardiovascular disease.

Authors:  Daniel Weitz; Howard Weintraub; Edward Fisher; Arthur Z Schwartzbard
Journal:  Cardiol Rev       Date:  2010 Sep-Oct       Impact factor: 2.644

4.  Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.

Authors:  Esther M M Ooi; Alice H Lichtenstein; John S Millar; Margaret R Diffenderfer; Stefania Lamon-Fava; Helen Rasmussen; Francine K Welty; P Hugh R Barrett; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-07-06       Impact factor: 5.922

5.  Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet.

Authors:  Xiao Tang; Zhao-Jie Li; Jie Xu; Yong Xue; Jin-Zhang Li; Jing-Feng Wang; Teruyoshi Yanagita; Chang-Hu Xue; Yu-Ming Wang
Journal:  Lipids Health Dis       Date:  2012-07-10       Impact factor: 3.876

Review 6.  Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.

Authors:  J Hartweg; R Perera; V Montori; S Dinneen; H A W Neil; A Farmer
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.